According to Skinbiotherapeutics latest financial reports the company has an operating margin of -22.44%, an decrease of -38.19% to 2022. At the end of 2022 company had an operating margin of -36.32%.
Year | Operating Margin | Change |
---|---|---|
2023 | -22.44% | -38.19% |
2022 | -36.32% | - |